| Cell Therapeutics, Inc. Q1 2010 Earnings Call Transcript Cell Therapeutics, Inc. (CTIC)Q1 2010 Earnings CallApril 28, 2010 8:30 am ETComplete Story » seekingalpha.com |
LATISSE® Wishes Challenge - Video LIFESTYLE DESIGNER KATHY IRELAND, PROFESSIONAL BALLROOM DANCER CHELSIE HIGHTOWER AND STYLE GUIDE BOBBIE THOMAS LEAD THE LATISSE® WISHES CHALLENGE CAMPAIGN TO BENEFIT THE MAKE-A-WISH FOUNDATION® feedproxy.google.com |
FDA Questions Avastin's Use in Breast Cancer The FDA questioned the benefit of using Roche's top-selling cancer drug for breast cancer, ahead of an advisory review of Avastin set for Tuesday. online.wsj.com |
Why Trainers Say, 'Slow Down' Research shows injury rates rise as runners increase their weekly mileage. Personal trainers and coaches are now helping Type-A runners realize their limits. online.wsj.com |
China Biotech Week in Review: Eddingpharm Raises $24 Million to Buy Western Drugs ChinaBio Today submits: Eddingpharm (Cayman) Inc., a Shanghai firm that seeks to in-license and then market Western drugs to hospitals in China, has closed a $24 million Series B financing (see story). The company said it would use the new capital to in-license additional drugs, co-develop prescription drugs for sale in China, and seek M&A opportunities. NeoStem (NBS) has signed a definitive agreement to acquire Progenitor Cell Therapy, LLC, a US cell therapy service company (see story). NeoStem, which left open the question of whether it would offer Progenitor's services in China, said the transaction will be immediately accretive to earnings. NeoStem will issue 11.2 million shares and warrants to purchase between 1 million to 3 million additional shares to the current owners of Progenitor, giving the deal a value of about $20 million. Complete Story » seekingalpha.com |